News
California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...
The Alzheimer's Association of Greater Kentucky and Southern Indiana held the kickoff party on Wednesday for its Walk to End ...
19h
Amazon S3 on MSNExploring Keto's Impact On Slowing Down Alzheimer's Disease..UC Davis have found that a keto diet might help delay the advancement of Alzheimer’s disease. A key molecule elevated by ketogenic diets, beta-hydroxybutyrate (BHB), delayed the early stages of memory ...
New University of Virginia School of Medicine research suggests an unexpected way doctors may be able to improve blood flow ...
A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...
3h
News Medical on MSNStandardized brain cell atlas to accelerate Parkinson's and Alzheimer's researchResearchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...
22h
Best Life on MSNScientists Find Shocking Link Between COVID and Alzheimer’sThe brain fog that can linger after a bout with COVID is not a new discovery. In fact, much research has linked this long-COVID symptom to the neuroinflammation that often accompanies an infection.
A large cohort study of older adults found that eating at least one egg per week was linked to a significantly lower risk of Alzheimer’s dementia.
Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...
Living with Alzheimer’s disease can be both challenging and frightening. However, stories of resilience and hope can inspire ...
We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results